The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE, Mass., Dec. 23, 2025 /PRNewswire/ -- Next Gen Diagnostics (NGD) today announced that January 1 the Company ...

Visit NGD at Booth #712 to learn more about the NGD system, which automates both sample preparation and bioinformatics, as well as generates actionable reports for Infection Prevention teams.

"The field has reached a turning point," said Dr. Paul A. Rhodes, CEO. "The capabilities required to enable broad adoption of sequence-based transmission detection ...

Next Gen Diagnostics, a global company providing fully automated, end-to-end whole-genome sequencing platform and bioinformatics pipeline, enabling hospitals to detect and prevent transmission in real ...